ScholarIQanswers from OpenAlex & ORCID
Michael Platten
ResearcherPublications, citations & collaboration network
Michael Platten is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael Platten have?
ScholarIQindexed works
Michael Platten has 807 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael Platten have?
ScholarIQcitation count
Michael Platten has 43,683 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael Platten?
ScholarIQh-index
Michael Platten has an h-index of 90 in OpenAlex.
What is the i10-index of Michael Platten?
ScholarIQi10-index
Michael Platten has an i10-index of 297 in OpenAlex.
What is the ORCID of Michael Platten?
ScholarIQorcid
The ORCID for Michael Platten is on the source record.
What is the OpenAlex record for Michael Platten?
ScholarIQopenalex
The OpenAlex for Michael Platten is on the source record.
What are the most-cited papers on Michael Platten?
ScholarIQmost cited works
Sarcoma classification by DNA methylation profiling
Christian Koelsche, Daniel Schrimpf, Damian Stichel, Martin Sill, Felix Sahm, David Reuß, Mirjam Blattner, Barbara C. Worst, Christoph E. Heilig, Katja Beck, Peter Horak, Simon Kreutzfeldt, Elke Paff, Sebastian Stark, Pascal D. Johann, Florian Selt, Jonas Ecker, Dominik Sturm, Kristian W. Pajtler, Annekathrin Reinhardt, Annika K. Wefers, Philipp Sievers, Azadeh Ebrahimi, Abigail K. Suwala, Francisco Fernández‐Klett, Belén Casalini, Andrey Korshunov, Volker Hovestadt, F. Kommoss, Mark Kriegsmann, Matthias Schick, Melanie Bewerunge‐Hudler, Till Milde, Olaf Witt, Andreas E. Kulozik, Marcel Kool, Laura Romero‐Pérez, Thomas G. P. Grünewald, Thomas Kirchner, Wolfgang Wick, Michael Platten, Andreas Unterberg, Matthias Uhl, Amir Abdollahi, Jürgen Debus, Burkhard Lehner, Christian Thomas, Martin Hasselblatt, Werner Paulus, Christian Hartmann, Ori Staszewski, Marco Prinz, Jürgen Hench, Stephan Frank, Yvonne M.H. Versleijen‐Jonkers, Marije E. Weidema, Thomas Mentzel, Klaus Griewank, Enrique de Álava, Juan Díaz‐Martín, Miguel Á. Idoate, Kenneth Tou En Chang, Sharon Y. Y. Low, Adrián Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek, Stefan Rutkowski, Ulrich Schüller, Viktor Mautner, Jens Schittenhelm, Jonathan Serrano, Matija Snuderl, Reinhard Büttner, Thomas Klingebiel, Rolf Buslei, Manfred Gessler, Pieter Wesseling, Winand N.M. Dinjens, Sebastian Brandner, Zane Jaunmuktane, Iben Lyskjær, Peter Schirmacher, Albrecht Stenzinger, Benedikt Brors, Hanno Glimm, Christoph Heining, Òscar M. Tirado, Miguel Sáinz‐Jaspeado, Jaume Mora, Javier Alonso, Xavier García del Muro, Sebastián Morán, Manel Esteller, Jamal Benhamida, Marc Ladanyi, Eva Wardelmann, Cristina R. Antonescu, Adrienne M. Flanagan, Uta Dirksen, Peter Hohenberger
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuß, Ralf A. Linker, Mathias Mäurer, Orhan Aktaş, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czapliński, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans‐Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding‐Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp, for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG)